# GALECTIN THERAPEUTICS INC: Form D filings

GALECTIN THERAPEUTICS INC, a pharmaceuticals company in Norcross, GA, filed 4 Form D notices with the SEC between 2011 and 2017. The latest, on January 6, 2017, reports $3 million sold of a $10 million offering to 5 investors.

Find out what GALECTIN THERAPEUTICS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20GALECTIN%20THERAPEUTICS%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=GALECTIN%20THERAPEUTICS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fgalectin-therapeutics-inc-1133416)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20GALECTIN%20THERAPEUTICS%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=GALECTIN%20THERAPEUTICS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fgalectin-therapeutics-inc-1133416)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Georgia](https://specstream.ai/data/form-d/state/georgia): 1,337 rows, by operating companies, filed since November 1, 2024, $66.85, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/georgia
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, Norcross, GA, 30071
- Phone: (678) 620-3186
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Nevada
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1133416

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jan 6, 2017 | New notice | $10,000,000 | $3,000,000 | $7,000,000 | 5 | Dec 22, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1133416/000113341617000001/0001133416-17-000001-index.htm) |
| Sep 28, 2016 | New notice | $12,000,000 | $1,500,000 | $10,500,000 | 1 | Sep 22, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1133416/000113341616000002/0001133416-16-000002-index.htm) |
| Dec 21, 2015 | New notice | Indefinite | $0 | Indefinite | 6 | Nov 25, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1133416/000113341615000001/0001133416-15-000001-index.htm) |
| Jan 12, 2011 | New notice | Indefinite | $2,250,000 | Indefinite | 22 | Dec 30, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1133416/000118143111003189/0001181431-11-003189-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Kevin D Freeman | Director |  |
| Gilbert S Omenn | Director |  |
| Harold H. Shlevin | Executive Officer |  |
| Theodore H. Zuconni | Director |  |
| Steven G. Prelack | Director |  |
| Gilbert F Amelio | Director |  |
| Marc G. Rubin | Director |  |
| James C Czirr | Director |  |
| John G. Mauldin | Director |  |
| Peter G Traber | Executive Officer, Director |  |
| Jack W Callicutt | Executive Officer |  |
| Arthur R Greenberg | Director |  |

## Other pharmaceuticals companies in Georgia that filed recently

- [Laurentide Therapeutics Inc.](https://specstream.ai/data/form-d/company/laurentide-therapeutics-inc-2157396) $99,999 · Sep 28, 2026
- [LifeCyte Innovations, Inc.](https://specstream.ai/data/form-d/company/lifecyte-innovations-inc-2150601) $1 million · Aug 20, 2026

[Every Form D from the week of Jan 2, 2017](https://specstream.ai/data/form-d/week/2017-01-02) · [All recent filings in Georgia](https://specstream.ai/data/form-d/state/georgia) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what GALECTIN THERAPEUTICS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).